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This paper reviews in silico models currently available for the prediction of skin permeability 
with the main focus on the quantitative structure-permeability relationship (QSPR) models. A 
comprehensive analysis of the main achievements in the field in the last decade is provided. In 
addition, the mechanistic models are discussed and comparative studies that analyse different 
models are discussed. (to be extended to 100--200 words) 
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1. Introduction  
Prediction of dermal absorption is an important research topic in the pharmaceutical and 
cosmetics sectors  and relates to the optimisation of the deposition and delivery of the active 
substances, as well as hazard and risk assessment. It is of particular interest in the light of the 
current EU regulations, such as REACH (Registration, Evaluation, Authorisation and Restriction of 
Chemicals) and Cosmetics Regulation  that strongly recommend or require use of alternatives to 
animal studies. The main benefits of theoretical predictions over experimental measurements 
include reduction of resources and resolving ethical issues. In addition, the models may assist in the 
better understanding of mechanisms of absorption. 
Prediction models are of particular interest in the light of the current EU regulations, such as 
REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) and Cosmetics 
Regulation that strongly recommend or require use of alternatives to animal studies. The Cosmetics 
Regulation has completely banned marketing of animal tested cosmetics ingredients and products in 
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the EU, requiring alternative methods for the safety assessment. Within the COSMOS project - part 
of the SEURAT-1 cluster co-funded by the European Commission and the Cosmetics Europe, the 
European cosmetics industry association – computational models to support the safety assessment 
of cosmetics-related substances were developed. For these substances the dermal exposure route is 
particularly important and therefore models for the prediction of skin permeation are needed to 
estimate the systemic availability via the dermal route. For example skin permeation models were 
used in the evaluation of the extension of the Thresholds of Toxicological Concern (TTC) approach 
to cosmetics and included in the decision tree developed to predict the systemic dose for 
comparison with the TTC derived from oral data (Williams et al 2016). 
There are two main types of predictive models for skin absorption: (i) quantitative structure-
permeability relationship (QSPR) models that relate skin permeability to chemical structure 
described by physico-chemical properties and other structural descriptors; these models rely on 
experimental data for skin permeability and build quantitative correlations using statistical 
approaches; and (ii) mechanistic models that take into account the heterogeneity of the skin 
structure in solute transport and are derived from first principles such as mass balance, relying on 
additional assumptions such as Fick’s laws of diffusion (Naegel et al., 2013). A number of the 
models reported are based on the general agreement that the rate-limiting step of permeation is 
often diffusion through the stratum corneum (SC), the outermost layer of the skin. Thus, an 
important challenge in modelling studies is to reflect the effect of the heterogeneous SC and the 
different possible absorption pathways, including transcellular absorption, intercellular absorption 
and appendageal absorption. Many studies regard passive diffusion through the lipid lamellae as the 
primary pathway. A smaller number of studies report the transcellular route to be important for 
passage of chemicals through the skin. Further challenges are how to model mixtures, transport 
from different vehicles, and the permeation of hydrophilic compounds. 
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This review provides a comprehensive analysis of the main achievements in modelling skin 
absorption with QSPR approaches during the last decade. In addition, the mechanistic models are 
discussed and comparative analyses of different models are provided. 
2. Skin structure and mechanisms of skin absorption 
In this section the main issues related to the structure and function of skin, as well as the 
mechanism of skin absorption, are briefly discussed in light of their role in the modelling of skin 
permeability. More detail on these topics can be found in several extensive reviews (e.g. Wiechers, 
1989; Singh & Singh, 1993; Schaefer & Redelmeier, 1996; Walters & Roberts, 2002; Madison, 
2003; Monteiro-Riviere, 2004, 2006). 
The skin is the primary barrier to systemic absorption of topically applied chemicals and a portal 
to the systemic delivery of transdermal medicaments (Monteiro-Riviere, 2006). Due to its large 
surface area and the cutaneous circulation, which comprises 5–10% of the total cardiac output, the 
skin is a major route of entry into the body for some exposure scenarios. As such, the skin provides 
a sturdy and flexible barrier to unwanted toxic substances and pathogenic microorganisms, to water 
and nutrients loss and responds to mechanical forces (elasticity and cushioning). Skin defence and 
repair includes touch, pain, and heat sensitivity, UV protection, cutaneous metabolism, 
immunological activity and inflammatory response to a foreign insult.  
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Fig. 1. Schematic representation of the skin structure: A – epidermis, B – dermis, C – hypodermis; 
1 – hair shaft, 2 – pore, 3 –hair erector muscle, 4 – sebaceous gland, 5 – sweat gland, 6 – hair 
follicle, 7 – blood vessel. 
 
The skin is a heterogeneous organ, containing a number of cellular layers, divided into distinct 
regions (Fig. 1). The epidermis is the outer region of embryonic ectodermal origin, which covers the 
connective tissue, while the dermis and the hypodermis are derived from the mesoderm (Kielhorn J 
et al. 2006). The epidermis has several layers with the following order from the external surface to 
inside: stratum corneum (SC, horny layer), stratum lucidum (clear layer), stratum granulosum 
(granular layer), stratum spinosum (spinous or prickle layer) and stratum germinativum (basal 
layer). The majority of cells in the epidermis are keratinocytes, formed by differentiation and 
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migration from the metabolically active basal layer. The cells of the adjacent layer, the stratum 
spinosum, are connected through desmosomes and other bridges and produce lamellar intracellular 
granules that, after fusion with the cell membrane, release neutral barrier lipids. The keratinocytes 
migrate to the outermost viable layer, the stratum granulosum, and are characterised by the presence 
of keratohyalin granules, polyribosomes, large Golgi bodies and rough endoplasmic reticulum.  
The top-most nonviable layer, the SC, is the major barrier to permeation within the skin (Fig. 2). 
It is 10–50 μm thick, metabolically inactive, with low water content (5-20%). It is composed of 
hexagonal cornified corneocytes that do not contain nuclei or cytoplasmic organelles. The majority 
of their cell content is keratin, a scleroprotein with chains linked by disulfide and hydrogen bonds. 
The corneocytes are connected by corneodesmosomes and their protein-rich cornified cell envelope, 
made up of highly cross-linked proteins (loricrin, involucrin, and filagrin) and provide covalent 
linkage sites for the surrounding non-polar barrier lipids (Madison, 2003, Norlen, 2008, Masters, 
So, 2001). The intercellular substance derived from the lamellar granules is present between the SC 
cells and forms the intercellular lipid component of a complex SC barrier, which prevents both the 
penetration of substances from the environment and the loss of body fluids (Monteiro-Riviere, 
2006). 
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Fig. 2. Schematic diagram of stratum corneum with the main transport routes (based on Barry, 
2001). 1 – cell cytoplasm, 2 – aqueous layer, 3 – lipid bilayers (ceramides, cholesterol, fatty acids),  
4 – plasma membrane, 5 – lipid, 6 – keratin 
 
The hydrophobic lipid composition of the intracellular spaces includes: 45–50% ceramides, 25% 
cholesterol, 15% long-chain free fatty acids, and 5% other lipids, the most important being 
cholesterol sulfate, cholesterol esters and glucosylceramides (Wertz et al., 1987; Law et al., 1995; 
Madison, 2003, de Jager et al., 2003; Ponec et al., 2003). The ceramides consist of a sphingosine or 
a phytosphingosine base to which a non-hydroxy, an -hydroxy, fatty acid is chemically linked. 
The length of the fatty acid chains is mostly between 24-26 methylene groups. Despite its low 
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content, cholesterol sulfate has been shown to be involved in the regulation of the desquamation 
process. How the skin lipids are organised architecturally is still not fully understood – both a single 
gel phase (Norlen, 2001) and the coexistence of a liquid crystalline and a crystalline phase 
(Bouwstra, Ponec, 2006; Forslind, 1994; Kitson et al., 1994) were  initially assumed. Later, a model 
based on bilayers of fully extended ceramides with asymmetrically distributed cholesterol 
molecules associated with the ceramide sphingoid moiety was proposed (Iwai et al., 2012). The 
authors speculated that a SC lipid matrix, in which cholesterol and free fatty acid segregated into 
different bands, allows for crystalline-like hydrocarbon chain packing on the fatty acid sides of the 
stacked extended ceramide bilayer system. In addition to keratinocytes, the epidermis contains two 
dendritic cell types, melanin producing cells, adjacent to the basal layer (melanocytes) and cells 
participating in the immune recognition in metabolically active epidermal layers (Langerhans cells) 
(Ahmed, 1979; Romani et al., 2003).  
A thin basement membrane separates the epidermis from the dermis (Fig. 1), where blood 
vessels, sensory nerves (pressure, temperature, and pain) and lymphatics are located. Its main 
functions are to provide nutritional support for the avascular epidermis, being a barrier to infection 
and a water storage organ. Beneath the dermis is a layer of loose connective tissue commonly 
known as the hypodermis (subcutis); it consists of superficial fascia with elastic fibres and aids in 
binding the skin to the underlying fascia and skeletal muscle (Monteiro-Riviere, 2006). The skin 
appendages originate in this layer: eccrine sweat glands, apocrine sweat glands, sebaceous glands 
and hair follicles with their associated erector muscles (Fig. 1).  
The transport of chemicals through the skin is a complex process, mediated by the following 
mechanisms: transcellular absorption (through the keratin-packed corneocytes by partitioning into 
and out of the cell membrane); intercellular absorption (around the corneocytes in the lipid-rich 
extracellular regions) and appendageal absorption (through the shunts provided by the hair follicles, 
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sweat glands, and sebaceous glands). The routes mediated by intercellular and transcellular 
absorption are considered as the most important for skin permeation of chemicals (Fig. 2). The 
tortuous intercellular pathway around the corneocytes has been identified as the major route of 
penetration across SC due to the relative impermeability of the cornified envelope, implying that SC 
lipids play a key role in the skin barrier function (Michaels et al., 1975; Elias, 1981; Grubauer et al., 
1987; Mao-Qiang et al., 1993; Bouwstra et al., 2001, 2003a; Ponec et al., 2003). The route 
associated with appendageal absorption may be important at early time points following application 
of the penetrant and in areas with significant density and size of appendages which may act as a 
drug reservoir for some materials (Kielhorn et al. 2006). 
 
3. Skin absorption parameters estimated in QSPR studies 
Typically QSPR models for skin absorption are based on experimental data derived from in vitro 
assays where steady-state conditions are ensured. The solute (penetrant) transport through the skin 
under steady-state conditions can be described by Fick’s first law. It relates the amount of a solute 
Q, crossing the skin membrane of area A, over a time period T, with the constant concentration 
gradient across the two interior surfaces of the skin Cs, the diffusion coefficient in the skin 
membrane D, and the path length h, as follows: 
Q =D . A . T . Cs / h         (1) 
Here the assumption is that the SC behaves like a pseudo-homogenous membrane. Thus the 
steady-state skin flux Jss (mol/cm2/hour) can be defined as: 
Jss = Q / (A . T) = (D . Cs) / h        (2) 
Commonly, the concentration at path length h is zero or very small (sink conditions). Also, the 
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concentration of the chemical at path length 0 is in a local equilibrium with the vehicle, and can be 
given by: 
C = Km . Cv           (3) 
where Km is the pseudo-homogeneous partition coefficient between the SC and the vehicle and Cv is 
the vehicle concentration. 
Under these conditions, eq. 2 becomes: 
Jss = D . Km  Cv / h = Kp  . Cv         (4) 
where Kp (permeability coefficient, cm/h) is the steady-state flux of the substance normalised by the 
concentration (remaining constant over a range of concentration values) Cv, i.e.: 
Kp = Jss / Cv           (5) 
It can be defined from eq. 4 as follows (Crank, 1975): 
Kp = D  Km / h          (6) 
The permeability coefficient Kp is the preferred dependent variable in the QSPR models. Usually 
it is calculated for an aqueous vehicle. Over time, a substantial database of experimentally 
determined Kp values from aqueous vehicles has been compiled, which is useful for deriving 
models (Mitragorti et al., 2011). 
Typically, the steady-state flux Jss is assessed from an in vitro experiments in which the donor 
concentration of the penetrant is maintained constant (i.e. infinite dose conditions), while the 
receiver phase provides “sink” conditions. Over time, the flux approaches a steady-state value and 
the cumulative amount penetrating the skin increases linearly with time. Jss is determined from the 
slope of the linear portion of the graph of the cumulative amount penetrated over the time. Kp is the Commented [AW3]: Would be nice to illustrate this 
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ratio of Jss and the vehicle concentration Cv (see eq. 5). 
The maximum flux, Jmax, will be observed when maximum solubility Ss of a solute in the SC is 
achieved, so that eq. 2 can be written as: 
Jmax = D  Ss / h          (7) 
Based on Kp and the maximal solubility of the chemical in the vehicle (Sv), the maximum flux 
can be represented as follows: 
Jmax = Kp . Sv          (8) 
Despite the fact that only few studies predict Jmax, it is a very useful parameter as it does not 
depend on the formulation, providing the formulation is saturated. Jmax should be constant as long as 
the chemical is at its maximum thermodynamic activity in the vehicle (Kroes et al., 2007). It must 
be noted that when calculating Jmax (eq. 8) Kp and Sv must be determined in the same vehicle. 
 
4. Main data sources for modelling purposes 
A large number of skin absorption data have been generated, some of them published in non-
proprietary sources. However, due to the lack of an established standard experimental procedure, 
there is high variability in experimental skin permeability values. This is as a result of the influence 
of a number of factors such as subject variability (i.e. species, sex and age), application site, dosing 
regime, occlusion, as well as inter-laboratory variations. Conversely, the key points for the 
development of predictive QSPR models are consistency and reliability of the experimental 
permeability data. Variations in the factors that influence these data increase the error and decrease 
the statistical reliability of the developed models (Moss et al., 2002a). 
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The section below shortly discusses the main datasets that have been published in the scientific 
literature and used for QSPR modelling (summarised in Table 1). 
Flynn dataset (Flynn, 1990). This was the first significant dataset of experimental permeability 
properties compiled. Due to this fact it is considered as a milestone in the development of QSPRs 
for skin permeability. It includes 97 permeability coefficients for 94 compounds, tested in vitro 
through human skin and in vivo in humans for toluene, ethyl benzene, and styrene (Flynn, 1990). 
The compounds cover a broad range of molecular weights (18 to 765) and logarithm of the octanol-
water partition coefficient (log P) values (−3 to 6); however the lipophilicity distribution is uneven 
– there are only small numbers of either highly lipophilic or highly hydrophilic compounds (Russell 
and Guy, 2009). Being a compilation of 15 different literature sources, this dataset has a high 
degree of uncertainty due to inter-laboratory and intra-laboratory variability including use of skin 
obtained from different sources and body locations (Moss et al., 2002a). Some groups have 
reanalysed the data included in the dataset. Johnson et al., 1995 re-examined the results for steroids 
previously measured by Scheuplein et al., 1969 and included them in the Flynn dataset. Degim et 
al., 1998 reanalysed other compounds (naproxen, atropine, and nicotine), for which experimental 
values differed by one or two log units from those published by Flynn. 
Wilschut et al. dataset (Wilschut et al., 1995). The dataset consists of 123 permeability 
coefficients for 99 different compounds applied in vitro to human skin in an aqueous solution and is 
compiled from the literature. These chemicals represent various chemical classes, including 
monoaromatic hydrocarbons, volatile halogenated hydrocarbons, phenols and steroids. 
Kirchner et al. dataset (Kirchner et al., 1997). A larger database of 114 skin permeability values 
was prepared from the Flynn dataset (51 chemicals, Flynn, 1990), together with additional data 
from regulatory reports (Health Canada, years range). However, the database contained 
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permeability coefficients for 63 compounds, which were not experimental values, but had been 
calculated using the “Potts and Guy” linear equation (Frasch and Landsittel, 2002, see below).  
Patel et al. dataset (Patel et al., 2002). Patel and co-authors compiled a comprehensive dataset 
containing 186 permeability coefficients for 158 structurally diverse compounds from human in 
vitro skin data of Flynn (1990) and Wilschut et al. (1995). They removed some compounds 
(atropine, diclofenac, naproxen, nicotine) that were considered as outliers. 
Vecchia et al. dataset (Vecchia et al., 2003). Vecchia and Bunge (2003a) collected a diverse 
data set of 170 permeability coefficients for 127 compounds covering molecular weights from 18 to 
584 and log P values from -3.1 to 4.6. 
Magnusson et al. dataset (Magnusson et al., 2004b). The complete dataset contains 278 Jmax 
values that are acquired or estimated from experimental data of various sources. The basic set 
includes Jmax values of 64 different solutes (87 records) from aqueous solution across a human skin. 
Additional records are available for: an aqueous vehicle with full- and split-thickness skin (56 
records); some pure solutes (34 records); an aqueous vehicle with ionisable solutes (54 records) and 
solutes from a propylene glycol vehicle (36 records). The data cover a wide range of 
physicochemical properties with log P values ranging from -5.7 to 8.7, molecular weight (MW) 
from 18 to 765 g/mol, melting point (Mpt) from 147 to 582 K and aqueous solubility (Saq) from 
6.9x10-7 mol/l to 8x10-6 mol/l. 
EDETOX database, 2004. It has been developed in the frame of multipartner EU project and is 
freely available from the University of Newcastle web page (http://research.ncl.ac.uk/edetox/). 
EDETOX contains over 4800 studies for 320 chemicals (Kielhorn et al. 2006). The database 
contains data from in vitro and in vivo percutaneous penetration studies using different species. 
EDETOX provides information about chemical name, vehicle used, origin of the skin sample, 
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membrane thickness, exposure time, length of study, percentage of dose absorbed, percentage 
recovery, flux, Kp, lag time, where available, and the source publications (Soyei and Williams, 
2004, Williams, 2006).  
Lian et al. dataset, 2008. The dataset is compiled from a number of publications (Wilschut et al., 
1995; Johnson, 1997; Patel et al., 2002; Mitragotri, 2003). Only human skin data are included. 
Altogether, there are 205 data points for 124 chemical compounds. MW values of the chemical 
compounds ranges from 18 to 765 and log P varies from -3.7 to 5.49. 
Oklahoma State University (OSU-KP) database, (Neely et al., 2009). It is based on published 
data in drug permeation enhancer studies and is developed to support modelling efforts. The criteria 
for inclusion are the following: (a) presence of well documented experimental conditions; (b) 
permeation coefficients measured under comparable circumstances; (c) structure of the included 
molecules generated and optimiSed using computational chemistry software; (d) Mpt and log P 
values of the molecules accurately calculated; (e) human or porcine skin is used. After applying 
these criteria, the OSU-KP database consisting of approximately 260 data points for 169 molecules 
was constructed for modelling studies. 
Lehman et al. dataset, 2011 (Lehman et al., 2011). The data are collected for compounds with 
absorption through human skin measured in vitro and in vivo. A total of 92 measured data were 
collected for 30 organic compounds; for some of these were from both in vitro and in vivo 
experiments conducted in the same laboratory. 
Samaras et al. dataset, 2012. The dataset is based on the EDETOX database extract and 
extended by data collected through an exhaustive literature search for human skin flux data. It 
contains 536 flux reports for 272 unique chemicals. The chemicals are either applied as neat 
(around 10% of the data) or formulated in simple mixtures with the majority of the vehicles 
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containing water as a constituent. In many cases, finite or infinite dosing conditions were specified 
explicitly in the source. In other cases, if the application volume is above 100 µl it is taken as 
‘infinite’, if donor volume is between 50 and 100 µl then, provided that the percentage of 
absorption is less than 20%, it is considered as an ‘infinite’, otherwise a ‘finite’ application.  
Chen et al. dataset, 2013. It consists of human skin permeability of hydrophilic solutes with low 
hydrophobicity (log P < 0.5) compiled from various published sources. In total there are 71 data 
points for 23 hydrophilic and 12 low hydrophobic solutes. 
Alves et al. datasets, 2015. Two in vitro skin permeability datasets with skin permeability 
coefficients were compiled from the literature − human and rodent data − consisting of 186 and 96 
compounds, respectively. The activity range of the compounds in the datasets is from −5.52 to 
−0.69 and from −4.85 to −0.94, respectively. 
Brown et al. dataset, 2016. A new in vitro skin permeability database is compiled from the 
literature. It contains 392 data points for 245 organic chemicals derived from human skin only and 
using only water as a vehicle. The range of the data in the dataset is the following: log P values 
from − 6.8 to 7.6; MW from 18 to 765 and log Kp from 5.8 to 0.1. 
 
Table 1. Summary of the main datasets used in skin absorption modelling studies. 
Data set 
Skin  
permeability 
parameter 
Number of 
compounds 
Total number of 
data records 
Flynn, 1990 Kp 94 97 
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For example: 
 
 In vitro or in vivo; human/pig/rodent etc 
 
 How many literature sources used to compile the dataset? (or how 
many different laboratories?) 
 
- featured characteristics of the dataset, e.g. broad structural diversity 
or specific chemical classes included: variability: only human data; 
only data with same vehicle considered… 
 
-MW / log P range, but probably not known for all datasets 
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Wilschut et al, 1995 Kp 99 123 
Kirchner et al., 1997 Kp 114 114 
Patel et al., 2002 Kp 158 186 
Vecchia et al., 2003 Kp 127 170 
Magnusson et al., 2004b Jmax 64 278 
EDETOX database, 2004 flux, Kp 320 >4800  
Lian et al., 2008 Kp 124 205 
OSU-KP database Kp 169 260 
Lehman et al., 2011 % absorbed 30 92 
Samaras et al., 2012 flux 272 536 
Chen et al., 2013 Kp 35 71 
Alves et al., 2015 Kp 186/96 211 
Brown et al., 2016 Kp 245 392 
 
5. Review of existing quantitative structure-skin permeability predictive models  
Since the beginning of the 1990s the modelling of the skin absorption has been exploited 
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intensively. A number of review articles have periodically discussed and analysed the models 
published in the scientific literature (Moss et al., 2002a; Vecchia & Bunge, 2003a,b; Walker et al., 
2003; Fitzpatrick et al., 2004; Geinoz et al., 2004; Degim, 2006; Kielhorn et al., 2006; Mitragorti et 
al., 2011; Moss et al., 2012; Anissimov, 2014, Dumont et al., 2015). The latter one reviews in 
addition in silico tools for the prediction of skin metabolism that are behind the scope of this paper, 
but does take into account that the skin is a metabolically competent organ and some chemicals are 
absorbed across the skin and metabolised into active compounds.  
There is a special issue “Modelling the human skin barrier—towards a better understanding of 
dermal absorption” of the Advanced Drug Delivery Reviews (volume 65, 2013) that gives an 
overview of the state of the art in the computational tools development. QSPR models are also 
discussed among the others. In addition, a number of comparative studies have evaluated the 
models developed (Bouwman et al., 2008; Lian et al., 2008; Farahmand et al., 2009; Brown et al., 
2012). 
In this paper we focus on the published QSPRs for skin absorption. A broader scientific area is 
considered by additionally involving models that predict skin enhancers’ (compounds penetrating 
into skin to reversibly decrease the barrier resistance) effectiveness, models accounting for the 
experimental conditions, and mechanistic models. A list of the published QSPR models is 
summarised in Table 2. 
5.1. QSPR models based on molecular size and/or lipophilicity parameters  
Most of the published QSPR models for passive, diffusion-controlled skin absorption are linear 
regression equations involving two structural descriptors. They indicate that molecular size 
(molecular volume (MV) or MW) and hydrophobicity (expressed as log P) are the main 
determinants of the transdermal penetration. The models are described by the following general 
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equation: 
log Kp = a + b log P − c MW        (9) 
In fact, eq (9) encapsulates the main parameters that play a role in the membrane permeation.  
Compound diffusivity is, in general, size dependent (large molecules diffuse more slowly than 
small ones). Various studies have investigated  whether MW or MV is a more effective parameter 
to describe molecular size in the models (Barratt, 1995; Potts & Guy, 1995; Patel et al., 2002). 
However, it must be pointed out that for datasets with relatively similar values for the MV/MW 
ratio, MW could be used as it is easier to derive. Otherwise, the MV is considered to provide better 
estimates (Kielhorn et al., 2006). 
Lipophilicity is experimentally determined as a partition coefficient (log P) or as a distribution 
coefficient (log D, referring to a pH-dependent mixture of neutral and ionic forms of the 
compounds). As a ratio of two concentrations at equilibrium, the partition coefficient is the net 
result of all intermolecular forces between a solute and the two phases between which it partitions 
(Geinoz et al., 2004). 
Potts and Guy (1992) described a simple QSPR based on permeant size (expressed as MW) and 
hydrophobicity (log P) to model the permeability coefficients collected by Flynn, 1990. The 
following equation is reported after removal of one outlier: 
log Kp = 0.71 log P − 0.0061 MW − 6.3       (10) 
n = 93, r2 = 0.67 
The above model has been discussed in a number of later studies (Moss et al., 2002b; Geinoz et 
al., 2004). The weakest point of the model is the incomplete statistics. On the other hand, the model 
has a clear mechanistic interpretation: as the permeants become more lipophilic, their permeability 
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increases due to better partitioning into the skin but, as they become larger, their diffusion into the 
skin is reduced. 
In the later work of Moss and Cronin, 2002b an improved version of Potts and Guy model, using 
MW and log P as descriptors, was provided. It is based on 116 compounds and yields good 
correlation between Kp and selected descriptors with r2 = 0.82 (a complete statistical analysis was 
reported). 
Shen et al. [2014] adopted the Potts and Guy model to fragrance ingredients. Motivated by the 
limitation that assumes 100% skin absorption for chemicals which lack experimental data, the 
authors developed a practical and mechanistically reasonable skin absorption model (SAM) specific 
for fragrance chemicals. The model relies on the methodology of Kroes et al. [2007] that proposed 
three different default skin absorption ranges depending on the Jmax values: <10% (Jmax ≤ 0.1 
μg/cm2/h) for poorly-absorbed chemicals; < 40% (0.1 μg/cm2/h < Jmax ≤ 10 μg/cm2/h) for 
moderately-absorbed chemicals; and ≤ 80% (Jmax >10 μg/cm2/h) for highly-absorbed chemicals. 
For 105 compounds with experimentally determined Kp values, the Potts and Guy's QSPR model 
was updated for Kp calculation and subsequently corrected according to Cleek and Bunge [1993] 
for Jmax calculation. In the final model log P and S were averaged from several software packages. 
Based on the SAM, the authors proposed a practical workflow for to predict skin absorption for 
fragrances. Applying it they demonstrated that none of the 131 chemicals used in the study had skin 
absorption >80%. 
In the frame of the European Union COSMOS project (http://www.cosmostox.eu/), which 
developed computational models for predicting the chronic toxicity of cosmetic-related ingredients, 
the estimation of bioavailability after dermal administration was among the important tasks. To this 
end, Steinmetz et al. rebuilt Potts and Guy’s QSPR by incorporating a larger dataset to increase the 
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applicability domain (to cite the poster? Alov et al, SEURAT meeting, 2015?). A statistical tool to 
assess data quality (cf. confidence score, CS) was used to improve the model robustness. It is based 
on the number and variability of conflicting data (Steinmetz et al., 2014). The compilation of skin 
permeability coefficient values from the literature resulted in 343 different Kp values being 
compiled for 226 compounds. Fifty-five of these compounds have more than a single Kp value, 
hence the arithmetic means and the confidence scores were calculated. Physico-chemical properties, 
i.e. MV and lipophilicity (XLogP) were calculated with the Chemistry Development Kit (CDK) 
within KNIME or EPI Suite. The model was validated with 10-fold cross-validation, which led to 
CS-adjusted RMSE (Root Mean Square Error) of 0.79 ± 0.2. The model is freely available through 
the COSMOS KNIME WebPortal (http://knimewebportal.cosmostox.eu/). 
The non-linear dependence of skin transport on chemical properties, particularly when diverse 
structures with broad range of log P values are considered, is of great interest for researchers. 
Parabolic dependencies on log P have been incorporated in some models to account for the non-
linear characteristics of the structure-property relationships (e.g. Lien and Gao, 1995). A non-linear 
regression QSPR model (SKINPERM QSPR model) was also developed by ten Berge (2009) using 
the measured Kp through human skin in vitro as a dependent variable and log P and MW as 
independent variables. The training set consisted of substances with a wide range of lipophilicity 
(log P between - 4.49 and 6.13). In total 182 measured permeability coefficients were used. The 
model is based on the assumption for two pathways of permeation in the SC – the transcellular 
route through the corneocytes and the intercellular route through the extracellular lipids (Fig. 2). A 
test set of 27 structures was used for external validation. It is reported that the predicted values are 
mostly within one order of magnitude of the experimentally observed values (no quantitative 
estimation of the external prediction is given). The model slightly overpredicts hydrophilic 
substances as reported in the later study of monopropylene glycol and dipropylene glycol (Fasano et 
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al., 2011). The reason, according to the authors, is underrepresentation of hydrophilic substances in 
the training group of the model. It is suggested that highly hydrophilic compounds do not cross the 
SC through the intercellular lipid matrix and, essentially, the only pathway available to these 
molecules is through the corneocytes. In this case, Jss and Kp are related only to MW and log P has 
no influence. Otherwise, log P is a determinant of the relative importance for the lipid intercellular 
pathway and the aqueous transcellular pathway across the SC (Fasano et al., 2011). 
The maximum flux is a valuable parameter of a solute’s dermal permeation. The advantage of 
Jmax compared to Kp is that it does not depend on the formulation applied (Kroes et. al., 2007; Zhang 
et al., 2009). However relatively few studies have predicted Jmax as a dependent variable in QSPR 
models. Kasting et al. (1987) developed a predictive model of log Jmax for 35 diverse drugs based on 
octanol solubility (log Soc) and MV. Magnusson et al. (2004b) developed a regression model to 
predict Jmax values from aqueous solution across human skin with MW only as a significant 
parameter: 
logJmax = -0.019MW – 3.90        (11) 
n = 87, r2 = 0.847, p<0.001 
The model was validated on different sets of compounds and a final model included all 278 
entries (multiple entries per compound). The model has r2 = 0.688. The addition of other 
physicochemical parameters such as Mpt and hydrogen bond (HB) acceptor capability only slightly 
improved the regression. The later work of Zhang et al. (2009) outlined that Jmax for similar sized 
phenolic solutes showed a bilinear relationship with lipophilicity. The key conclusion was that for 
more lipophilic solutes, the dependence of Jmax on lipophilicity resulted from variations in SC 
solubility, and not from diffusional or partitioning barrier effects at the SC–viable epidermis 
interface. 
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5.2. Multiparameter models 
Lipid-water partition coefficients, solubility, melting point, molecular size and hydrogen bonding 
have been recognised as the main structural determinants of structure – skin penetration 
relationships. A number of multiparameter models have been proposed in the literature extending 
the approaches broadly referred to as QSPRs above. Such multiparameter models incorporate more 
descriptors and thus may result in improved fit. In addition, inclusion of more structural parameters 
in the QSPR equations could help for in a better mechanistic understanding (Mitragotri et al., 2011), 
but may be restrained by statistical criteria if techniques such as regression analysis are used. 
The transformed Potts & Guy and Roberts & Sloan equations correlate the maximum flux of 
solutes with their MW, as well as aqueous (Saq) and lipid (isopropyl myristate, Sipm)solubilities. . 
The basis for the dependence of the maximum flux on Saq as well as Sipm has been attributed to the 
existence of a high-capacity lipid-aqueous series pathway in addition to a parallel lower-capacity 
lipid-only pathway through the SC (Roberts and Sloan, 1999, 2000). 
Linear free-energy relationship (LFER) models are based on a number of physicochemical 
parameters relevant to solute solvation processes (Abraham et al., 1997; Abraham and Martins, 
2004; Zhang et al., 2012). The model uses the following descriptors of the penetrants: HB donor 
acidity, HB acceptor basicity, dipolarity/polarisability, excess molar refractivity (MR), and 
McGowan’s characteristic volume (the MV calculated by a 2-D fragment contribution method). As 
such, it attempts to reflect the importance of molecular size, i.e. in the MV term, and log P is 
represented indirectly in the form of MV, polarisability, MR and HB activity. 
The importance of hydrophobicity, molecular size and HB ability to model skin absorption was 
also mentioned by Patel at al. (2002). They developed a multiple linear regression (MLR) QSPR 
models for a training set of 158 compounds. The most significant parameters were logP, MW, 
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sssCH (the sum of E-state indices for all methyl groups) and ABSQon (the sum of absolute charges 
on oxygen and nitrogen atoms). 
The aim of the work of Magnusson et al. (2004a) was to develop simple rules for rapid screening 
of compounds with potentially high dermal absorption by predicting Jmax. The model was based on 
MW, Mpt, log P, log S and the number of atoms available for HB - subdivided into HB donor (HB-
d) and acceptor (HB-a) atoms. According to the authors, these properties reflect the fundamental 
determinants of flux - size, polarity, and HB capacity. Linear discriminant analysis was used for 
model derivation with the following boundary values reported:  
(i) Bad penetrants: MW > 213g/mol; Mpt ≥ 223K; HB-d ≥ 0; HB-a ≥ 3; log P > 1.2; log S < -1.6 
(ii) Good penetrants: MW ≤ 152g/mol; Mpt ≤ 432K; HB-d ≤ 2; HB-a ≤ 3; log P < 2.6; log S ≥ -
2.3 
The success of the predictor combinations was quantified with the most significant prediction from 
the combination of three descriptors MW/ HB/ log P or MW/ log S/ Mpt,  with a correct prediction 
rate of approximately 70%. 
Xu et al. (2013) further elaborated the discriminant rules and reduced them in number to two. 
Thus solutes with MW ≥ 400 or log P 1 or log P 4 were considered poor penetrants. Further 
these authors proposed an U-optimal distance-based design procedure for the selection of training 
and test sets that meet the conditions of having a wide coverage of the structural space, maximal 
diversity within training and test sets and maximal similarity between them. For that purpose they 
use a large candidate set of 4534 solutes. 
The study of Baert et al. (2007) on a set of 116 compounds from the literature using 1630 
parameters is interesting from a statistical point of view. The authors classified the compounds into 
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a distinct number of permeability classes using the CART (classification and regression trees) 
methodology and developed statistical models using a boosted CART, BRT approach and MLR 
analysis. The best models were based on lipophilicity/ hydrophobicity and molecular 
stereochemical complexity. 
Basac et al. (2007) developed multiparameter QSPR models using 101 compounds from the 
Patel et al. (2002) dataset. The models were based on topostructural, topochemical, shape or three-
dimensional (3D) descriptors and quantum chemical indices. The statistical methods applied were 
ridge regression (RR), principal components regression (PCR) and partial least squares regression 
(PLS). Full statistical analysis of the models has been reported. The cross-validated correlation 
coefficients for the full set and subsets were 0.67 – 0.87. The RR results were found to be superior 
to PLS and PCR regressions. The models indicated that HB descriptors, molecular size, branching 
and cyclicity can be highly significant in predicting dermal absorption and can be considered as 
general descriptors necessary for its modelling. 
An attempt to elucidate how skin permeability relates to the skin sensitisation potential of 
chemicals (skin permeability has been identified as a necessary step in the OECD AOP for skin 
sensitisation) was performed by Alves et al. (2015) who derived QSAR models to predict human 
skin permeability by applying the random forest method (RFM). The curated dataset included 186 
unique compounds with log Kp values in the range from -5.52 to -0.69, retrieved from the literature 
(Chauhan and Shakya, 2010; Flynn, 1990). A number of 2D structural descriptors were calculated 
by the DRAGON (Talete, SRL, Milan, Italy) and HitQSAR software (Kuz’min et al, 2008). The 
best RFM QSAR models were compared to those obtained by the DERMWIN module in the 
EPISuite package (US EPA, 2006); the latter estimated log Kp by the two parameter (log P and 
MW) MLR model. The best RFM model showed better external predictivity than the DERMWIN 
model (predictive q2 of 72% vs. 43%, respectively) considering the applicability domain restriction 
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(the coverage of the chemical space 77% vs. 100%, respectively). When compared to the same set 
of compounds (143 compounds, 100% coverage), the predictive accuracy of both models more 
similar (71% vs. 66%, respectively).  
In the more recent multiparameter studies there is a tendency toward considering the non-linear 
nature of the skin penetration in the models. Thus, some studies investigated the possible non-
linearity of the data and use further non-linear methods for modelling. Moss et al. (2009) revealed 
inherent non-linearity of the used skin permeability dataset by applying principal component 
analysis (PCA) and further explored the utility of Gaussian processes to develop a predictive model. 
The authors compared their model with previously published QSPR models and a single linear 
network model and concluded that the non-linear approach was more appropriate for the analysis of 
the dataset employed. Fatemi and Malekzadeh (2012) developed linear and nonlinear models based 
on MLR and artificial neural network (ANN) methods. The dependent variable was the 
experimental flux (in log scale). The CODESSA software was used to generate the molecular 
descriptors. No priority was given to any of the models in the study, however consideration of the 
statistical parameters indicated ANN were slightly better. The better performance of non-linear 
models was described by Neely at al. (2009) using ANN. 
In summary, the recent trend in the QSPR modelling using multiparameter models is to explore 
wider and more diverse datasets with structures described by a large number of descriptors and to 
combine various statistical methods to derive predictive models. Some of these studies have focused 
on the methodological aspects aiming at testing and comparing different statistical procedures, 
others attempted to obtain a more detailed insight into the mechanisms of absorption. Generally, 
careful attention should be paid to the physicochemical and biological meaning of a model, 
otherwise the interpretation of models can be quite complicated and not justified mechanistically. 
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5.3. QSPR models for transdermal enhancers 
Penetration enhancers are designed to facilitate the transport of compounds with limited 
percutaneous absorption and thus are of interest for delivery systems in the pharmaceutical and 
cosmetic industries. Their effectiveness is measured as an Enhancement Ratio (ER), which is the 
ratio of the flux in the presence of a fixed concentration of an enhancer to the delivery rate when the 
enhancer is missing in the formulation. Mechanisms of enhancement include interaction with 
intercellular lipids of the SC, interaction with intracellular proteins of the corneocytes or increasing 
partitioning of the solute into the SC due to the presence of the enhancer (Iyer et al., 2007). 
Modelling the effectiveness skin penetration enhancers is a relatively new field and classical QSPR 
models may help predict the ER ratio of enhancers. In more recent studies experimental and 
molecular modelling approaches have been applied to help in elucidating the mechanisms of action 
of the enhancers. 
Karande et al. (2005) investigated more than 100 enhancers representing several chemical 
functionalities. Using Fourier transform infrared spectroscopy they showed that, regardless of their 
chemical nature, the enhancers perturb the skin barrier via extraction or fluidisation of the lipid 
bilayers. They proposed two kinds of models, respectively, for extractors and fluidisers. The models 
correlated the ratio ER/IP (IP, irritation potential) with dominant molecular features that govern 
changes in the microscopic organisation of the SC (log P, HB capacity, polarity, and dispersion). 
These models point to the main constraints in optimising the balance between the potency and 
membrane safety of the enhancers. Based on the models, the authors designed more than 300 
potential enhancers that were screened in silico and subsequently tested in vitro for molecular 
delivery. Of them, 110 showed ER/IP > 3.8 thus confirming the usefulness of the models. 
A dataset of dermal enhancers was collated by Pugh et al. (2005) and classified using 
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discriminant analysis. The dataset has been further exploited using several machine learning 
methods, including the K-nearest-neighbour regression, single layer networks, radial basis function 
networks and the SVM classifier (Moss at al., 2012). The best classification results were obtained 
with the SVM method without dealing with imbalanced data. 
Iyer at al. (2007) reported QSPR models for four skin penetration enhancer datasets differing in 
the structures of the enhancers and penetrants. The models use classical and 4D-fingerprint 
descriptors. Based on the different descriptors in the best QSPR models for the different datasets, 
the authors conclude that there are different mechanisms of penetration that depend on the 
chemistry of the enhancer as well as that of the penetrant molecule. 
Zheng et al. (2008) used classical QSPR models and a model, denoted as MI-QSAR (Membrane-
Interaction QSAR), to investigate penetration enhancers. The data involved 103 transdermal 
penetration surfactant-like and nonpolar enhancers, of different chemical nature, collected from 
experimental studies. In total, 24 classical QSAR intramolecular (HOMO, LUMO, dipole moment, 
MV, MW, MR, polar surface area (PSA), number of HB acceptors and donors, Kier and Hall 
topological descriptors, partial atomic charges etc.) and intermolecular (aqueous and 1-octanol 
solvation free energies, log P, hypothetical phase transition temperatures, etc.) descriptors were 
used. QSPR models were built and optimised by MLR and the genetic function approximation 
(GFA). The MI-QSAR models featured descriptors determined from the trajectories of molecular 
dynamics (MD) simulation of a transport of an organic compound through a phospholipid 
monolayer or bilayer (dimyristoylphosphatidylcholine molecules, DMPC, used in MD). The most 
informative MD parameter was the integrated spatial difference which captured the time-average 
change in the structure of the monolayer molecular assembly due to the presence of an embedded 
molecule, in this case, a penetration enhancer. This descriptor dominated the MI-QSAR models and 
greatly reduced their size and complexity as compared to the QSAR models developed using classic 
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intramolecular descriptors derived solely from the structure of penetration enhancers of comparable 
statistical characteristics. The integrated spatial difference parameter is relatively straightforward to 
interpret: the bigger the “holes” created in the monolayer by the penetration enhancer, the greater 
the value of the ER. The next informative, but less significant descriptors, were the classical 
aqueous solvation free energy and dipole moment (in one model) and PSA and Kappa topological 
index (in another model). Overall, the MI-QSAR models indicated that good nonpolar penetration 
enhancers make larger “holes” in the monolayer and preferentially enter the monolayer. The study 
was a step forward to a better understanding of the mechanisms of enhanced transport through the 
skin and supports the evidence about interactions of the enhancers with intercellular lipids of the 
SC, which leads to a disorganisation of these highly ordered structures and, thus, enhances the 
intercellular diffusivity through the SC. Additionally, it can increase the partition of the compound 
into the SC. 
To explore the structure–activity relationship for terpenes as transdermal penetration enhancers, 
unsaturated menthol analogues were synthesised and evaluated in vitro by Chen et al.  (2013). 
Molecular modelling was applied to investigate the enhancer induced alteration in different skin 
lipid domains. The results suggested that polar head groups of the SC lipids are the main binding 
site for enhancer’s action. Thus, the authors concluded that the compounds studied enhanced drug 
transport by interacting with the polar domain of the skin lipids, instead of affecting the 
arrangement of the hydrophobic chains. According to the docking results the compound with the 
best enhancement activity had the greatest affinity to the polar groups of the ceramides. Therefore, 
its preferential interaction with the polar group of the lipids was offered as a reasonable explanation 
for its best enhancement activity.  
The opportunities of using MD methodology to predict the mechanism of action of skin 
enhancers were well reviewed by Notman and Anwar (2013). The limitations related to the long 
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time- and length-scale processes and the main challenges related to the lack of definitive 
experimental data about the organisation of the skin lipids were discussed. The MD case studies 
were reviewed including DMSO coarse grained and atomistic simulations, ethanol atomistic 
simulations and oleic acid coarse-grained simulations. 
5.4. Models accounting for the formulation and experimental conditions 
The models of Potts and Guy, and Abraham and Martins, together with their variations are based 
on measurements from an infinite dose in aqueous solution, which is not sufficient to predict 
absorption from a more complex multicomponent vehicle and under finite dose conditions, which is 
a more realistic exposure scenario. As a determinant of percutaneous absorption, it is well known 
that the delivery vehicle is as important as the penetrant itself. An increase in the complexity of the 
delivery vehicle (formulation) also increases the potential for interactions to occur between the 
chemical, vehicle and skin consequently affecting the absorption process. In vitro studies have 
shown that the interactions arising within the chemical–vehicle–skin system synergistically alter the 
chemical’s ability to partition into and diffuse through the skin barrier (Karadzovska and Riviere, 
2013). Therefore, in order to be useful for realistic risk assessment estimates, vehicle and mixture 
component effects should also be considered in the QSPR models. These facts motivated the 
development of the chemical mixture models (Riviere and Brooks, 2005, 2007, 2011). In addition to 
the descriptors involved in the models of Potts and Guy and Abraham and Martins, these models 
incorporate properties of the solvent or the mixture through the so-called “mixture factor” (MF) 
which account for mixture interactions by using physicochemical properties of the mixture 
components. The MF is calculated based on percentage composition of the vehicle/mixture 
components and physicochemical properties selected using PCA (Riviere and Brooks, 2005, 2007, 
2011). 
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Modelling the effect of mixture components on the permeation, Ghafourian et al. (2010a, b) 
found that compounds formulated in vehicles with small boiling and melting point gaps would be 
expected to have higher permeation through skin. The models developed by Samaras et al. (2012) 
incorporate the effects of the in vitro experimental conditions by using parameters such as skin 
thickness, exposure type, and states of pre-hydration or occlusion of the skin. In the linear models 
the most prominent factors influencing permeability were the donor concentration, lipophilicity, 
size and polarity of the penetrants and the difference between the melting and boiling points of the 
vehicles; in the non-linear models skin occlusion played the most significant role. 
Gutha et al. (2014) proposed an in silico prediction model that considered mixture-related 
effects. The authors adopted the MF approach of Riviere and Brooks (2005, 2007, 2011) to predict 
dermal absorption of new substances from specific formulations. The data set contained 56 test 
substances applied in more than 150 mixtures in in vitro experiments utilising human and rat skin. 
The compounds’ structures were described by the Abraham descriptors; the physicochemical 
parameters for the mixture ingredients were log P, the topological polar surface area (TPSA), HBA 
and HBD. In total, 87 MFs were calculated as descriptors for each mixture of a test substance. The 
MLR equation for the penetrant-predictive mixture model involved the five Abraham descriptors 
and MF; in addition, the species indicator and the receptor fluid indicator variables were set. The 
final valid model included R2, TPSA and the species indicator, however,  statistical analysis was 
relatively poor (r2 (goodness of fit) = 0.38, Q2LOO (internal validation by leave-one-out procedure) = 
0.35, Q2EXT (external predictivity) = 0.41). In addition, a ‘formulation-predictive mixture’ model 
was developed, in which the substance-specific descriptors were replaced by a class variable (a 
parameter that bundles the experimental outcome for one specific substance applied in several 
formulations). This model yielded a better fit (r2 = 0.75) and predictivity (Q2EXT = 0.73) and could 
be applied during formulation development to assess the absorption effects. 
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As already discussed, most QSPRs are developed for infinite dose conditions. In practice, dermal 
exposure mostly occurs under finite dose conditions. A simple model to predict finite dose dermal 
absorption from infinite dose data (Kp and lag time) and the SC/water partition coefficient (KSC/W) 
was developed by Buist et al. (2010). For the predictions QSPRs were used to estimate the KSC/W. 
The predicted values were either similar to the measured in vitro values or overestimated them. 
Kasting and co-workers developed a model that takes into account the transient conditions or the 
time dependency of skin penetration (reviewed in Dancig et al., 2013). These are actually real-life 
exposure situations, such as a finite dose, short exposure times, multiple exposures and/or removals. 
In addition, the model takes into account the skin heterogeneity. The simulations require only the 
chemical structure. The partition and diffusion coefficients were estimated from physical properties 
which can be obtained exclusively from the molecular structures. The model is implemented in a 
web-based program (http://www.cdc.gov/niosh/topics/skin/finiteSkinPermCalc.html).  
 
5.5. Mechanistic models 
The majority of the QSPR models are developed with the assumption that the intercellular lipid 
pathway is the route of transdermal permeation and the corneocytes are impermeable. However, as 
mentioned above, it appeared that the lipid-pathway models are not suitable for to predict the skin 
permeability of hydrophilic solutes. Generally, statistical QSPR models underpredict the skin 
permeability of hydrophilic solutes by 2–6 orders of magnitude (for log P < -2) and thus they are 
limited to hydrophobic compounds (Chen et al., 2013).  
Mass-balance, or mechanistic, models attempt to predict skin permeability by taking into account 
the heterogeneous structure of the skin barrier rather than assuming it as a pseudo-homogenous 
membrane. Usually the skin is presented by the “brick-and-mortar” model – bricks represent the 
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corneocytes and mortar represents the lipid phase (Talreja et al., 2001). The transport of solutes 
through different routes of diffusion (pathways of transdermal permeation) is considered. 
The model of Mitragotri (Mitragotri, 2003) considered four routes of diffusion: (i) free-volume 
diffusion through lipid bilayers; (ii) lateral diffusion along lipid bilayers; (iii) diffusion through 
pores; and (iv) diffusion through shunts. The model relates the aqueous pores in the SC lipids and 
shunts to the aqueous pathway, while the corneocytes are considered impermeable. The contribution 
of the shunts to the skin permeability is estimated to be independent of molecular size and property. 
The model appears to predict the skin permeability of hydrophilic solutes well. 
The biphasic microtransport model (Wang et al., 2006, 2007) considers both the intercellular and 
transcellular pathways, but suggests that SC permeation for most compounds is dominated by the 
transcellular pathway regardless of their lipophilicity. It fails to give a satisfactory prediction of the 
skin permeability of hydrophilic solutes due to the fact that the solute transfer across the lipid phase 
is represented by a transfer coefficient, obtained by fitting to skin permeability data which include 
mostly hydrophobic solutes.  
The model of Chen et al. (Chen et al., 2010, 2013) described three types of mass transfer of 
solutes as follows: (i) in the lipid matrix; (ii) in the corneocyte phase, and (iii) across the lipid–
corneocyte interface. The solute transfer in the lipids contributes to both the intercellular pathway 
and the transcellular pathway due to its continuous nature, whereas the solute transfer in 
corneocytes and across the lipid–corneocyte interface is related only to the transcellular pathway. 
Hydrophilic solutes are still considered to be able to partition into the SC lipid according to log P, 
without separately lending to aqueous pores. The results indicate that the transcellular pathway is 
very important for the transdermal permeation of hydrophilic solutes and can contribute to more 
than 95% of the overall skin permeability.  
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6. Conclusions 
In recent years many efforts have been invested in developing predictive and reliable QSPR 
models for skin permeability. Some simple models have been derived that are quite useful for 
screening purposes. A good example is the Potts and Guy model, which provides adequate 
predictions based on a simple two-parameter regression equation and has been widely used for 
many years. However, the complex biological mechanisms regulating dermal absorption and the 
numerous factors involved in this process represent a challenge and set higher requirements to the 
theoretical predictive approaches, whose use is increasingly encouraged in both pharmaceutical and 
safety assessment area.  
In the present review, a comprehensive discussion on the currently available methods for the 
prediction of skin absorption is presented, focusing on quantitative structure-permeability 
relationships. Limitations and strengths of different approaches are highlighted together with the 
emergent issues and perspectives. One of the key limitations in the prediction of skin absorption 
stems from the data used to develop the QSPR models. Many of these models are developed from 
datasets with limited chemical heterogeneity, while others are compiled from various investigators 
and laboratories employing different experimental protocols resulting in a high variability of data. 
The experimental skin permeability datasets have mostly been collected for aqueous vehicles, using 
infinite conditions. This leads to an additional limitation of the models, since in the real-life 
situations finite doses are applied for short exposure times. 
Based on the analysis of the existing models and following the good practice for developing 
robust and predictive QSPR models several recommendations can be specified for the purposes of 
the skin permeability QSPRs:  
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(i) High-quality data are required. It is recommended that the data be adjusted for similar skin 
origin and experimental conditions. Additionally, an assessment of the chemical space of 
the current data is recommended. Different forms of the dependent variable (permeability 
parameter) can be experimentally derived, e.g. the maximum flux could be a more 
suitable parameter than the permeability coefficient to account for dermal absorption 
potential;  
(ii) Special attention is to be given to the outliers in the data including applicability domain 
outliers. The process of the outlier detection should also consider mechanistic reasoning;  
(iii) Special attention is also to be paid to variable scaling and descriptor significance, as models 
based on non-significant descriptors do not afford mechanistic insights and may lead to 
overfitting of the data. Selection of the most informative descriptors is to be performed 
on a rational base that is directly related to the mechanism of the skin permeability; 
(iv) A combination of linear and non-linear methods is to be considered in the modelling 
process. Such a combination could allow for a more adequate description of the 
behaviour of solutes of different physicochemical nature; 
(v) Experimental conditions are to be taken into consideration when the training and test sets are 
generated as they could have a significant impact on the prediction results. Especially, the 
effects of the non-aqueous solvents and formulations (including vehicles and skin 
enhancers) should be considered and some modelling efforts are to be put on simulation 
of finite dose conditions and on considering the heterogeneous skin structure.  
 
Table 2. Summary table of the QSPR models for skin permeability in chronological order (for the 
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abbreviations see the list below the table) 
Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
Flynn 
(1990) 
Kp 
----------------- 
literature sources 
(Flynn data set) 
94 - MW, log P qualitative 
model 
El Tayar et al. 
(1991) 
Kp 
----------------- 
literature sources 
18 ÷ 22 LR ΔlogP(o-h), 
logP 
 
2-parameters 
 model of 
Potts & Guy 
(1992) 
Kp 
----------------- 
Flynn dataset 
(Flynn, 1990) 
93 LR MW, log P no outlier 
analysis 
3-parameters 
model of 
Potts & Guy 
(1995) 
Kp 
----------------- 
Flynn dataset 
 
37 LR MV, Hd, Ha  
Wilschut et al. 
(1995) 
Kp 
----------------- 
various literature 
sources 
99    
Barratt 
(1995) 
Kp 
----------------- 
Flynn dataset 
 
60 ÷ 91 LR MV, log P, mpt hydro-cortisones 
excluded from the 
data set 
Lien & Gao 
(1995) 
Kp 
----------------- 
Flynn dataset 
16 ÷ 23 LR, 
parabolic 
MW, log P, 
(log P)2, Hb 
in vivo data used for 
the lipophilic vehicle 
Commented [AR46]: Can no. of compounds in test and training 
sets be given? 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
=========== 
R in vivo 
----------------- 
(Lee et al.1994) 
regression (ethanol and 
panasate 800) 
Abraham 
LFER models 
(Abraham et al, 
1995, 1997) 
Kp 
----------------- 
various literature 
sources 
46  (1995) 
53  (1997) 
LR Abraham solute 
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
 
Kirchner et al. 
(1997) 
Kp 
----------------- 
Flynn dataset  + 
regulatory  data 
(Health Canada) 
114 
(51 from 
Flynn data set) 
 
LR MV, log P Kp for 63 compounds 
calculated with the 
Potts & Guy model 
Cronin et al. 
(1999) 
Kp 
----------------- 
Flynn dataset; 
(Kirchner et al, 1997) 
107 ÷ 114 LR MR, log P, 
HLP,  4χv 
 
 
Pugh et al. 
(2000) 
log (D/h) 
----------------- 
(Wilschut et al. 
1995; Degim et al, 
1998) 
41  
 
PCA and LR Charge, MW 57 log Kp and  
log (D/h) values used 
Lim et al. 
(2002) 
Kp 
----------------- 
Flynn dataset 
92 LR, ANN QC descriptors: 
dipole, 
polarizability, 
sum(N,O), sum(H) 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
Moss et al. 
(2002) 
Kp 
----------------- 
Flynn dataset; 
(Kirchner et al, 1997; 
Johnson et al, 1995; 
Degim et al, 1998) 
116 LR Log P, MW, 
 
steroid data replaced;  
data re-analysed 
Patel et al. 
(2002) 
Kp 
----------------- 
Flynn dataset & 
(Wilschut et al, 1995) 
143 ÷158 LR Log P, MW, 
SsssCH, ABSQon 
      
Estrada et al. 
(2003) 
flux  
----------------- 
(Ursin et al., 1995) 
12 commercial 
solvents 
 
LR Methyl groups 
bonded to 
heteroatoms or to 
CH2 groups 
 
in vivo  living skin,  
topological sub-
structural approach 
 in the modelling 
 
Moody & 
MacPherson 
(2003) 
Kp 
----------------- 
Flynn dataset; 
(Kirchner et al, 1997) 
39 ÷ 71 LR MW, log P, 
surface tension in 
water 
Pannier et al, 
(2003) 
Kp 
----------------- 
Flynn dataset;  
data from Abraham et 
al. (1997) 
37-94 Cluster 
analysis 
(ANFIS) 
MW, log P; 
Abraham solute 
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
Abraham 
LFER model 
(extended) 
(Abraham & 
Martins, 2004) 
Kp 
----------------- 
various literature 
sources 
 
119 LR Abraham solute 
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
 
Kp values adjusted 
for ionisation and 
temperature 
Magnusson et 
al. 
(2004) 
Jmax 
 
278 LR  Jmax values 
estimated from the 
product of the 
reported Kp and Saq) 
Geinoz et al. 
(2004) 
Kp 
----------------- 
Flynn dataset; 
(Kirchner et al, 1997); 
various literature 
sources 
20 ÷ 107 Stepwise LR MW, MR, 
log P,  Vw 
Abraham solute 
descriptors: πH2, 
ΣαH2, ΣβH2 
 
Karande et al. 
(2005) 
ER / IR (enhancement 
ratio / irritation 
potential) 
----------------- 
own data  
102 
enhancers 
(extractors and 
fluidisers) 
Non-linear 
relations 
Log P, Hb, 
polarity, 
dispersion 
Different equations 
for extractors and 
fluidisers 
Chemical 
mixture model 
(Riviere & 
Brooks, 2005) 
Kp 
----------------- 
own data 
16 compounds 
 
288 treatment 
combinations 
LR Compounds: 
Abraham solute 
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
 
Vehicles:  MF 
Vehicle: 
water, 
ethanol, 
propylene glycol 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
 
Pugh et al., 
2005 
ER 
----------------- 
literature sources 
73 skin 
enhancers 
Discriminant 
analysis 
carbon chain 
length, HB 
numbers, MW 
Katritzky et al. 
(2006) 
Kp 
various literature 
sources 
143  LR; ANN log Pexp, Kier & 
Hall index; 
rotational entropy; 
Zefirov Partial 
Charge, H-
acceptor FCPSA; 
molecular 
fragments 
CODESSA PRO and 
ISIDA software used 
Ding et al. 
(2006) 
CE=10 
(Chantasart et al. 
2004) 
16 skin 
enhancers  
Stepwise LR Log P, position of 
the hydroxyl group 
branched-chain 
alkanols used 
Majumdar et 
al. 
(2006) 
Jmax 
Flynn dataset 
62-76 LR MW, solubilities 
in octanol (Soct) 
and water (Saq) 
Roberts & Sloan  
(transformed Potts & 
Guy) model 
Neumann et al.  
(2006) 
Kp 
(Wilschut et al. data 
set; other sources 
110 RR and 
k-nearest-
neighbour 
SOLV, log P, MW  
Basak et al. 
(2007) 
Kp 
(Patel et al. 2002) 
22 ÷ 101 RR, PCR, 
PLS 
hydrogen bonding 
descriptors, 
molecular size, 
branching and 
cyclicity 
Kirchner at al., 1997 
dataset dropped from 
the data 
Iyer et al., 
(2007) 
ER 
various literature 
sources 
Four datasets: 
61, 44, 42, and 
MLR classic QSAR 
descriptors and 
4D-fingerprint 
descriptors developed 
Commented [M47]: Line stile? 
Commented [M48]: Line stile? 
Commented [M49]: Line stile here and to the end. 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
17 compounds 4D-fingerprints by the 4D-QSAR 
paradigm. 
Stoick et al. 
(2007) 
Kp 
various literature 
sources 
CHEP +10 
structural 
analogues 
LR MW, log P DERMWIN™ model 
(US EPA, 2006) 
Baert et al. 
(2007) 
Kp 
literature sources 
(Magnusson et al, 
2004 ; Patel et al., 
2002 ; Buchwald et al, 
2001) 
116 PCA, 
CART, 
stepwise LR 
10 most 
significant: 
lipophilic, 2D 
topological, 
3D MoRSE, 
shape-related, etc. 
1630 descriptors 
generated 
Iontophoretic 
model 
(Mudry et al, 
2007) 
flux through pork skin 
characterized by to 
C+ 
own data 
16 cations LR & 
nonlinear 
regression 
MW, 
cation 
hydrodynamic 
radius, 
cationic mobility 
 
Luo et al. 
(2007) 
Kp 
literature and 
regulatory sources 
 
340 
 
 Log P, χ0,  SsssCH 
 
MDL’s QsarIS 
software for the other 
descriptors; 
306 compounds out 
of 340 used in the 
training set 
Chemical Kp 
 (in vitro PSFT 
10 ÷ 12 Stepwise LR Compounds: 
Abraham solute 
descriptors: 
24 mixtures 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
mixture model 
(extended) 
(Riviere & 
Brooks, 2007) 
diffusion cells) 
 
AUC 
(IPPSF ex vivo model) 
own data 
compounds 
 
50 ÷ 288 
treatment 
combinations 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
 
Vehicles: MF 
  
(in vitro PSFT 
diffusion cells) 
 
5 mixtures 
(IPPSF ex vivo 
model) 
 
Yamaguchi et 
al. 
(2008) 
DSC and 
DVED  in vitro 
own data on rat skin 
10 LR, 
parabolic 
regression 
Log P, HBD  
MI-QSAR 
model 
(Zheng et al. 
2008) 
ER(J) 
skin penetration 
enhancement 
various literature 
sources 
103 
enhancers 
 
penetrants: 
hydrocortisone 
& 
hydrocortisone 
acetate 
LR integrated spatial 
difference (MD 
parameter), 
aqueous solvation 
free energy; dipole 
moment; PSA,  
Kappa topological 
index 
24 classical QSAR 
descriptors derived; 
 
MD parameter 
derived from MD 
trajectories of 
simulations in DPMC 
layers 
Liou et al. 
(2009) 
Kp 
own data 
13 non-
steroidal anti-
inflammatory 
drugs 
LR MW, solubility 
parameter , 
biological 
parameters of the 
skin (elasticity and 
hydration of the 
Model is workable 
for drugs with  
Log P < 2 Commented [M50]: ? 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
skin) 
Neely et al. 
(2009) 
Kp 
Oklahoma state 
university database 
(OSU-KP) 
160 GA,  ANN, 
LR 
most significant: 
L3s, log P, 
nArCOOR, 
number of single 
bonds, polarity 
over 1500 descriptors 
generated with 
CODESSA and 
Dragon software 
ten Berge 
(2009) 
Kp 
(Vecchia & Bunge, 
2003)° 
+12 additional 
compounds 
182 Nonlinear 
regression 
MW, log P  
Zhang et al. 
(2009) 
Jmax 
own data 
10 nonlinear 
regression 
Log P Similar size 
of the structures 
Buist et al. 
(2010) 
finite dose absorption, 
(%) 
own data 
Equations 
based on  Kp 
and lag time 
(infinite 
dose 
experiments 
 Used QSARs to 
estimate the KSC,W 
 
Chauhan & 
Shakya 
(2010) 
Kp 
various literature 
sources 
150-153/58 
training 
set/test set 
GA, iPLS log P, Snar and 
hydrogen bond 
acceptors 
e-DRAGON and 
ADME Pharma 
Algorithms-
Abrahams descriptors 
Commented [M51]: ? 
Commented [M52]: ? 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
 
Ghafourian et 
al. (2010a) 
Kp 
own data 
12 
compounds; 
24 solvent 
mixtures 
Stepwise LR log P,  9χp, 
SolBP–SolMP 
 
TSAR 3D software 
 
Ghafourian et 
al. (2010b) 
Kp 
own data 
96 new Kp 
values + 288 
Kp values 
from (Riviere 
et al., 2005) 
Stepwise LR log P,  9χp, 
SolBP–SolMP 
 
TSAR 3D software 
 
Lee at al. 
(2010) 
Pe 
own data 
61 
 
MLR PISA, donorHB,  
accptHB, glob; EA 
 
44 non-proprietary 
structures provided in 
the table;  
PEG 400 used as the 
organic 
co-solvent 
 
Chemical 
mixture model 
(extended) 
(Riviere & 
Brooks, 2011) 
Kp 
 (in vitro PSFT 
diffusion cells) 
 
AUC 
(IPPSF ex vivo model) 
16 ÷ 20   
compounds 
 
119 ÷ 384 
treatment 
combi-nations 
Stepwise LR Compounds: 
Abraham solute 
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
 
Vehicles: MF 
(the best MF 
descriptors 
HBA, 1/Mp) 
Vehicle: 
water, 
ethyl alcohol, 
propylene glycol, 
sodium lauryl sulfate, 
methyl-nicotinic acid 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
own data 
Fatemi & 
Malekzadeh 
(2012) 
flux  
(Fiserova-Bergerova 
et al, 1990) 
132 LR; ANN 7 electronic, 
quantum-
chemical, 
topological 
parameters 
Flux measured in 
mg/cm2.h; 
CODESSA software 
used for descriptors 
LFER 
model of 
Abraham 
(united) 
(Zhang et al, 
2012) 
 
Kp 
(Abraham and 
Martins, 2004; 
Singh et al, 1994); 
measurements of 18 
ionized solutes 
118 LR Abraham solute 
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
 
Extra terms for 
ionic solutes: 
J+, J- 
Neutral and ionic 
solutes 
simultaneously 
included in the model 
Moss et al., 
2012 
ER 
---------------- 
From Pugh et al., 
2005 
71 skin 
enhancers 
Various 
machine 
learning 
methods 
log P, log S, MW, 
carbon chain 
length, HB 
numbers 
Sun et al. 
(2012) 
Kp 
---------------- 
literature sources 
19-140 PCA, GP MW, solubility 
parameter, log P, 
counts of the 
number of 
hydrogen bonding 
acceptor (HA) and 
donor groups (HD) 
 
Human, pig, 
rodent, and synthetic 
membrane 
permeability data 
used 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
Samaras et al. 
(2012) 
flux 
----------------- 
various literature 
sources and EDETOX 
database 
272 
compounds 
(neat or in 
mixtures) 
 
Stepwise 
LR, RT 
Compounds: 
(donor), MW, 
vsurf G, 
SlogPVSA4, 
fiAB, VAdjMa 
 
Vehicles: 
BP−Mp(mix) 
Models incorporate: 
membrane thickness 
and finite/infinite 
dosing; 
Vehicle: 
water, 
polyethy-lene-
glycols, petro-latum, 
mineral 
oil 
Chemical 
mixture model 
(artificial 
membranes) 
(Karadzovska & 
Riviere, 2013) 
absorption 
through 
3 artificial membranes 
 
---------------- 
own data 
6 compounds 
 
32 treatment 
combinations 
Stepwise 
LR 
Compounds: 
Abraham  
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
 
Vehicles: MF 
 
Indicator variables 
for: 
- vehicles 
- saturation 
 
Vehicle: 
propylene glycol, 
water, ethanol 
Chen et al., 
2013 
ER 
---------------- 
own data 
Four 
penetration 
enhancers 
 
docking  Docking calculations 
performed using 
AutoDock software 
Gutha et al., 
2014 
Kp 
---------------------- 
56 compounds 
 
MLR 
Stepwise 
Compounds: 
Abraham 
descriptors: 
ΣαH2, ΣβH2, πH2, 
R2, Vx 
Two models 
proposed: 
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Model 
Parameter * 
----------------- 
data source 
No. of com- 
pounds 
Statistical 
method 
Significant 
descriptors 
Note 
own data more than 
150 mixtures 
MLR 
PCR 
Mixtures: MF  
(log P, TPSA, 
HBA, HBD) 
Indicator variables 
for species and 
receptor fluid 
Class variable 
“penetrant-predictive 
mixture” model  
(moderate statistics) 
“formulation-
predictive mixture” 
model  
Shen et al., 2014 Kp 
---------------------- 
Flyn data set 
EDETOX database 
 
105 
compounds 
MLR MW, log P Model used for 
calculation of Jmax 
and percent 
absorption values of 
fragrance chemicals  
Steinmetz et al., 
2015 
Kp 
---------------- 
literature sources 
226 
compounds 
MLR Log P, MW Confidence Scoring 
used to improve 
robustness of the 
model 
Alves et al., 
2015 
Kp 
--------------- 
Chauhan and Shakyia 
Flynn data set 
186  
compounds 
RFM 2D DRAGON 
and SiRMS 
descriptors; 
DRAGON and 
HitQSAR software 
used for calculation 
of the descriptors 
* Log-form used as a dependent variable in the models with Kp, R, flux, D, AUC, Pe, CE=10 and absorption. 
 
List of abbreviations used in Table: 
3D MoRSE: 3D-MoRSE (3D-Molecule Representation of Structures based on Electron diffraction) 
Commented [AR53]: Publication from 2014 or 2015? 
Commented [AR54]: Based on Potts &Guy? 
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descriptors 
ABSQon: Sum of absolute charges on oxygen and nitrogen atoms 
accptHB: Number of hydrogen bonds that would be accepted by the solute in solution 
ANN: Artificial Neural Network 
ANFIS: Adaptive Neural Fuzzy Inference System 
AUC: Area under the curve 
BP: Boiling point 
BP−Mp(mix): Difference between the boiling and melting points of the mixture (donor phase) 
CE=10: Aqueous solution concentration of an enhancer that could yield 10-fold permeant transport 
enhancement to the control (no enhancer present)  
CART: Classification and regression trees 
CHP: Hydroxyethylpiperazine, a commercial mixture of 1,4-piperazinediethanol, piperazine, 
hydroxyethylpiperazine, and water 
D: Diffusion coefficient in the skin membrane  
DSC, DVED: Diffusion coefficients in stratum corneum (SC) and viable epidermis and dermis (VED) 
DMPC: Dimyristoylphosphatidylcholine 
(donor): Donor concentration (g/ml) 
donorHB: Number of HB that would be donated in solution 
EA (eV): Quantum mechanically calculated electron affinity 
ER(J): Skin penetration enhancement: the ratio of hydrocortisone (HC) or hydrocortisone acetate 
(HCA) penetration with, and without, a common fixed concentration of the test enhance 
fiAB: Fraction of molecules ionized as anion and cation at pH 7.4 
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FCPSA: Fractional charged partial surface area 
GA: Genetic algorithm 
glob: Globularity descriptor (molecular shape descriptor) 
GP: Gaussian processes 
H: Path length in the skin (see Eq. 1) 
Ha:  Hydrogen bond acceptor activity 
Hb: Hydrogen bond forming ability (donor hydrogens + acceptor electron lone pairs) 
Hd:  Hydrogen bond donor activity 
HLP: Total number of lone pairs that can accept hydrogen bonds on the molecule 
HBA: Hydrogen bond acceptor number 
HBD: Hydrogen bond donor number 
iPLS: Interval partial least-squares algorithm 
IPPSF: Isolated perfused porcine skin flap model,  an ex vivo biologically intact perfused tissue 
preparation shown to correlate to in vivo human dermal absorption 
J+, J-: Extra terms for ionic solutes ( J+ = 0 for anions,  J− = 0 for cations; J+= J- = 0 for neutral 
compounds) 
Jmax: Maximum skin flux, mg/cm2.h 
Kp Permeability coefficient 
KSC,W: Stratum corneum/water partition coefficient 
L3s: 3rd component size directional WHIM index / weighted by atomic electrotopological states 
(WHIM: weighted-holistic-invariant molecular) (Todeschini et al., 1997), 
http://www.vcclab.org/lab/indexhlp/whimdes.html 
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Log P:  logarithm of the octanol/water partition coefficient 
ΔlogP(o-h): log P(octanol) – log P(heptane) 
LR: Linear regression 
MD: Molecular dynamics 
MF: Mixture factor (accounts for physicochemical properties of the vehicle/mixture components) 
MLR Multiple linear regression 
Mpt: Melting point 
MR:  Molecular refractivity 
MV:  Molecular volume 
MW:  Molecular weight 
nArCOOR: Number of esters 
PCR: Principal components regression 
Pe: Normalised permeability 
PISA: pi (carbon and attached hydrogen) component of solvent-accessible surface area 
PLS: Partial least squares regression 
PSA: Polar surface area 
PSFT: in vitro porcine skin flow-through diffusion cells 
R: Rat skin permeability= log(%permeation/(100-%permeation) 
R2:  Excess molar refractivity, cm3 mol−1 )/10 (Abraham solute descriptor) 
RFM Random forest method 
RR: Ridge regression 
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RT: Regression tree 
Saq: Aqueous solubility 
SiRMS 2D simplex representation of molecular structure 
SlogPVSA4: Sum of van der Waals surface area of atoms with log P contributions in the range of (0.1–
0.15) (MOE, 2011) 
Snar: Narumi simple topological index (related to molecular branching) 
SolBP–SolMP: Difference between melting and boiling points of the solvent mixtures 
SOLV: Solvation free energy in water computed with MOPAC2002 using the COSMO continuum 
solvation model 
SsssCH: Sum of E-state indices for all methyl groups 
sum (H): sum of charges of hydrogen atoms bonding to nitrogen or oxygen atoms 
sum(N,O): sum of charges of nitrogen and oxygen atoms 
toC+: Cation transport number in the skin  
TPSA: Topological polar surface area 
VAdjMa: Vertex adjacency information which depends on the number of heavy-heavy bonds (MOE, 
2011) 
Vx:  McGowan characteristic volume of the solute in (cm3  mol−1)/100 (Abraham solute 
descriptor) 
Vw: van der Waals volume 
vsurfG: Molecular globularity–how spherical a molecule is, where values above 1 is non-perfect 
spheres (Cruciani, 2000) 
πH2:  Dipolarity/polarisability (Abraham solute descriptor) 
ΣαH2:  Hydrogen bond donor acidity (Abraham solute descriptor) 
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ΣβH2:  Hydrogen bond acceptor basicity (Abraham solute descriptor) 
4χv: Fourth order valence-corrected molecular connectivity 
χ0: Zero order molecular connectivity chi index (quantification of both the molecular size and 
the degree of skeletal branching) 
9χp: 9th order path molecular connectivity index 
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